COMPOSITION CONTAINING β-GLYCYRRHETINIC ACID AND ZINC GLUCONATE

Title:

COMPOSITION CONTAINING β-GLYCYRRHETINIC ACID AND ZINC GLUCONATE

Document Type and Number:

Japanese Patent JP2023094854

Kind Code:

A

Abstract:

To provide a composition that inhibits neutrophil collagenase activity.SOLUTION: An oral composition contains β-glycyrrhetinic acid and zinc gluconate. A content of the zinc gluconate is 0.06-7.5 pts.mass relative to 1 pt.mass of the β-glycyrrhetinic acid in the oral composition.SELECTED DRAWING: None

More Like This:

JP2005526832	Pharmaceutical composition containing α-ketoalkanoic acid ester or -amide and lactic acid or lactate
JP4002391	Aminoethyl phenoxyacetic acid derivative and pain relieving and stone removal promoter for urolithiasis
JPH02501142	[Title of the Invention] A biologically active compound

Inventors:

URAKAWA RIKA
ARITA TAKUYA

Application Number:

JP2021210408A

Publication Date:

July 06, 2023

Filing Date:

December 24, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SUNSTAR INC

International Classes:

A61K31/19; A61K8/365; A61K8/63; A61K31/191; A61P1/02; A61P43/00; A61Q11/00

Attorney, Agent or Firm:

Saegusa International Patent Office

Previous Patent: Alkyldiaminoethylglycine and/or its salt-containing composition

Next Patent: Composition containing β-glycyrrhetinic acid and ethylenediaminetetraacetic acid and/or its salt